These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17244768)

  • 1. Incorporating in vitro information on drug metabolism into clinical trial simulations to assess the effect of CYP2D6 polymorphism on pharmacokinetics and pharmacodynamics: dextromethorphan as a model application.
    Dickinson GL; Rezaee S; Proctor NJ; Lennard MS; Tucker GT; Rostami-Hodjegan A
    J Clin Pharmacol; 2007 Feb; 47(2):175-86. PubMed ID: 17244768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.
    Capon DA; Bochner F; Kerry N; Mikus G; Danz C; Somogyi AA
    Clin Pharmacol Ther; 1996 Sep; 60(3):295-307. PubMed ID: 8841152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.
    Nagai N; Kawakubo T; Kaneko F; Ishii M; Shinohara R; Saito Y; Shimamura H; Ohnishi A; Ogata H
    Biopharm Drug Dispos; 1996 Jul; 17(5):421-33. PubMed ID: 8830977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.
    Abduljalil K; Frank D; Gaedigk A; Klaassen T; Tomalik-Scharte D; Jetter A; Jaehde U; Kirchheiner J; Fuhr U
    Clin Pharmacol Ther; 2010 Nov; 88(5):643-51. PubMed ID: 20881950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP; Michel C; Hofmann U; Jacqz-Aigrain E; Kroemer HK; Peraldi MN; Eichelbaum M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextrorphan and dextromethorphan: comparative antitussive effects on guinea pigs.
    Braga PC; Fossati A; Vimercati MG; Caputo R; Guffanti EE
    Drugs Exp Clin Res; 1994; 20(5):199-203. PubMed ID: 7875056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
    Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
    J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.
    Dorado P; Heras N; Machín E; Hernández F; Teran E; Llerena A
    Eur J Clin Pharmacol; 2012 May; 68(5):637-44. PubMed ID: 22083166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6.
    Chen R; Rostami-Hodjegan A; Wang H; Berk D; Shi J; Hu P
    Eur J Pharm Sci; 2016 Sep; 92():131-6. PubMed ID: 27412587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
    Kukanich B; Papich MG
    J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
    Streetman DS; Ellis RE; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitussive effect of dextromethorphan in relation to CYP2D6 activity.
    Abdul Manap R; Wright CE; Gregory A; Rostami-Hodjegan A; Meller ST; Kelm GR; Lennard MS; Tucker GT; Morice AH
    Br J Clin Pharmacol; 1999 Sep; 48(3):382-7. PubMed ID: 10510150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic effects of dextromethorphan are altered by the CYP2D6 polymorphism: a pilot study.
    Zawertailo LA; Kaplan HL; Busto UE; Tyndale RF; Sellers EM
    J Clin Psychopharmacol; 1998 Aug; 18(4):332-7. PubMed ID: 9690700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing polymorphic metabolism in drug discovery: evaluation of the utility of in vitro methods for predicting pharmacokinetic consequences associated with CYP2D6 metabolism.
    Gibbs JP; Hyland R; Youdim K
    Drug Metab Dispos; 2006 Sep; 34(9):1516-22. PubMed ID: 16763018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan.
    Desmeules JA; Oestreicher MK; Piguet V; Allaz AF; Dayer P
    J Pharmacol Exp Ther; 1999 Feb; 288(2):607-12. PubMed ID: 9918565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Chinese herbal formula "Zuojin Pill" on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
    Qiu F; Liu S; Miao P; Zeng J; Zhu L; Zhao T; Ye Y; Jiang J
    Eur J Clin Pharmacol; 2016 Jun; 72(6):689-95. PubMed ID: 27023460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
    Borges S; Li L; Hamman MA; Jones DR; Hall SD; Gorski JC
    Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
    Spanakis M; Vizirianakis IS; Mironidou-Tzouveleki M; Niopas I
    Biomed Chromatogr; 2009 Nov; 23(11):1131-7. PubMed ID: 19444798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium ozagrel on the activity of rat CYP2D6.
    Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
    Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.